Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.

A Novel Approach to Orthotopic Hepatocyte Transplantation Engineered With Liver Hydrogel for Fibrotic Livers, Enhancing Cell–Cell Interaction and Angiogenesis

Open access

Abstract

Hepatocyte transplantation (HCT) is a potential bridging therapy or an alternative to liver transplantation. Conventionally, single-cell hepatocytes are injected via the portal vein. This strategy, however, has yet to overcome poor cell engraftment and function. Therefore, we developed an orthotopic HCT method using a liver-derived extracellular matrix (L-ECM) gel. PXB cells (flesh mature human hepatocytes) were dispersed into the hydrogel solution in vitro, and the gel solution was immediately gelated in 37°C incubators to investigate the affinity between mature human hepatocyte and the L-ECM gel. During the 3-day cultivation in hepatocyte medium, PXB cells formed cell aggregates via cell–cell interactions. Quantitative analysis revealed human albumin production in culture supernatants. For the in vivo assay, PXB cells were encapsulated in the L-ECM gel and transplanted between the liver lobes of normal rats. Pathologically, the L-ECM gel was localized at the transplant site and retained PXB cells. Cell survival and hepatic function marker expression were verified in another rat model wherein thioacetamide was administered to induce liver fibrosis. Moreover, cell–cell interactions and angiogenesis were enhanced in the L-ECM gel compared with that in the collagen gel. Our results indicate that L-ECM gels can help engraft transplanted hepatocytes and express hepatic function as a scaffold for cell transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/09636897241253700

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. (A) Protocol for preparing decellularized liver hydrogel and the characteristics of liver-derived extracellular matrix (L-ECM) gel. The porcine liver is minced using a food dicer. This decellularization takes 5 days. Subsequently, freeze-drying and solubilization were performed. The appearance of pre-decellularized tissues, post-decellularized tissues, and hydrogel is shown. (B) Pie graph from proteomic analysis of the liver and L-ECM gel. (C) The ratio of matrisome components in L-ECM gel detected by proteomic analysis. (D) Hierarchical clustering analysis of matrisomes in the liver and the L-ECM gel.
Figure 1. (A) Protocol for preparing decellularized liver hydrogel and the characteristics of liver-derived extracellular matrix (L-ECM) gel. The porcine liver is minced using a food dicer. This decellularization takes 5 days. Subsequently, freeze-drying and solubilization were performed. The appearance of pre-decellularized tissues, post-decellularized tissues, and hydrogel is shown. (B) Pie graph from proteomic analysis of the liver and L-ECM gel. (C) The ratio of matrisome components in L-ECM gel detected by proteomic analysis. (D) Hierarchical clustering analysis of matrisomes in the liver and the L-ECM gel.CC BY-NC · PubMed Central
Figure 2. Characterization of HepG2 in L-ECM gel according to the viscoelasticity of the L-ECM gel. (A) Viscoelasticity of the L-ECM gel. Ultrasoft, soft, medium, and hard characteristics were determined by complex viscoelastic modulus (E′E′′ [kPa]). The collagen concentration is described as a line graph. (B) Electron microscopy of the L-ECM gel. (C) The appearance of hepatocytes (HepG2) in the L-ECM gel in vitro according to the viscoelasticity of the gel. Scale bar, 50 μm. (D) Human albumin production by hepatocytes (HepG2) in culture medium according to the gel viscoelasticity. (E) Relative gene expression of hepatocytes (HepG2) according to gel viscoelasticity. (F) Immunostaining analysis of HepG2 cells encapsulated in the L-ECM gel. Scale bar, 50 μm.
Figure 2. Characterization of HepG2 in L-ECM gel according to the viscoelasticity of the L-ECM gel. (A) Viscoelasticity of the L-ECM gel. Ultrasoft, soft, medium, and hard characteristics were determined by complex viscoelastic modulus (E′E′′ [kPa]). The collagen concentration is described as a line graph. (B) Electron microscopy of the L-ECM gel. (C) The appearance of hepatocytes (HepG2) in the L-ECM gel in vitro according to the viscoelasticity of the gel. Scale bar, 50 μm. (D) Human albumin production by hepatocytes (HepG2) in culture medium according to the gel viscoelasticity. (E) Relative gene expression of hepatocytes (HepG2) according to gel viscoelasticity. (F) Immunostaining analysis of HepG2 cells encapsulated in the L-ECM gel. Scale bar, 50 μm.CC BY-NC · PubMed Central
Figure 3. In vitro analysis of hepatocyte (PXB) function in the L-ECM gel vs collagen gel. (A) Scheme of the in vitro analysis of hepatocytes (PXB) in the L-ECM gel. (B) The appearance of hepatocytes in vitro in the L-ECM gel on days 0 and 1. Scale bar, 200 μm. (C) Human albumin production by hepatocytes in the culture medium. There is no statistically significant difference between PXB in the L-ECM and collagen gels. (D) Immunostaining of hepatocytes in the L-ECM gel. Scale bar, 50 μm. (E) Gene expression in the hepatocytes. The expression of AFP, ALB, and EPCAM is not significantly different between hepatocytes in the L-ECM gel and those in the collagen gel. LKB1, CLDN1, and CLDN4 expression is significantly higher in the L-ECM gel than in the collagen gel. (F) Hierarchical clustering profiles of hepatocytes encapsulated in the L-ECM (n = 3) and collagen gels (n = 1). Higher expression relative to the median expression value (black) is indicated in yellow, and lower expression is indicated in blue. (G) Gene ontology (GO) analysis of hepatocytes encapsulated in the L-ECM gel vs collagen gel. The y-axis refers to GO categories. The x-axis shows the GO scores. * and ** indicate P < 0.05, P < 0.10, respectively.
Figure 3. In vitro analysis of hepatocyte (PXB) function in the L-ECM gel vs collagen gel. (A) Scheme of the in vitro analysis of hepatocytes (PXB) in the L-ECM gel. (B) The appearance of hepatocytes in vitro in the L-ECM gel on days 0 and 1. Scale bar, 200 μm. (C) Human albumin production by hepatocytes in the culture medium. There is no statistically significant difference between PXB in the L-ECM and collagen gels. (D) Immunostaining of hepatocytes in the L-ECM gel. Scale bar, 50 μm. (E) Gene expression in the hepatocytes. The expression of AFP, ALB, and EPCAM is not significantly different between hepatocytes in the L-ECM gel and those in the collagen gel. LKB1, CLDN1, and CLDN4 expression is significantly higher in the L-ECM gel than in the collagen gel. (F) Hierarchical clustering profiles of hepatocytes encapsulated in the L-ECM (n = 3) and collagen gels (n = 1). Higher expression relative to the median expression value (black) is indicated in yellow, and lower expression is indicated in blue. (G) Gene ontology (GO) analysis of hepatocytes encapsulated in the L-ECM gel vs collagen gel. The y-axis refers to GO categories. The x-axis shows the GO scores. * and ** indicate P < 0.05, P < 0.10, respectively.CC BY-NC · PubMed Central
Figure 4. Hepatocyte (PXB) transplantation with the L-ECM gel in normal rats. (A) Scheme of the surgical procedure for hepatocyte transplantation. The peeled-off surface is indicated by arrows. (B) Immunosuppressive agent protocol. FK, tacrolimus, mPSL, and hydrocortisone sodium succinate. (C) Albumin concentration in rat blood samples on days 3, 5, and 7 after transplantation (n = 3). (D) Macroscopic, (E) hematoxylin and eosin (H&E), and immunostaining results. The L-ECM gel was placed between the liver lobes (white arrow). Cells were detected in the L-ECM gel by H&E staining. (F) Immunostaining of hepatocytes in the L-ECM gel; PXB cells (CK8/18, human albumin-positive) expressing CYP3A4. Claudin-1 was expressed in PXB cells. Scale bar, 50 μm.
Figure 4. Hepatocyte (PXB) transplantation with the L-ECM gel in normal rats. (A) Scheme of the surgical procedure for hepatocyte transplantation. The peeled-off surface is indicated by arrows. (B) Immunosuppressive agent protocol. FK, tacrolimus, mPSL, and hydrocortisone sodium succinate. (C) Albumin concentration in rat blood samples on days 3, 5, and 7 after transplantation (n = 3). (D) Macroscopic, (E) hematoxylin and eosin (H&E), and immunostaining results. The L-ECM gel was placed between the liver lobes (white arrow). Cells were detected in the L-ECM gel by H&E staining. (F) Immunostaining of hepatocytes in the L-ECM gel; PXB cells (CK8/18, human albumin-positive) expressing CYP3A4. Claudin-1 was expressed in PXB cells. Scale bar, 50 μm.CC BY-NC · PubMed Central
Figure 5. Rat model of drug-induced liver fibrosis using thioacetamide (TAA). (A) Protocol for TAA administration and blood examination. (B) Changes in serum levels of ALT, AST, and albumin in rats. There were no statistically significant differences. (C) Macroscopic, H&E, and azan staining of resected liver after TAA administration. The table below shows the degree of liver fibrosis according to the Inuyama classification. Scale bar, 1 cm or 50 μm. (D) qRT-PCR of the resected liver after TAA administration. The expression of MMP, Col, and Vegf was significantly elevated upon TAA administration compared with that observed in the controls. * and ** indicate P < 0.05 and P < 0.10, respectively.
Figure 5. Rat model of drug-induced liver fibrosis using thioacetamide (TAA). (A) Protocol for TAA administration and blood examination. (B) Changes in serum levels of ALT, AST, and albumin in rats. There were no statistically significant differences. (C) Macroscopic, H&E, and azan staining of resected liver after TAA administration. The table below shows the degree of liver fibrosis according to the Inuyama classification. Scale bar, 1 cm or 50 μm. (D) qRT-PCR of the resected liver after TAA administration. The expression of MMP, Col, and Vegf was significantly elevated upon TAA administration compared with that observed in the controls. * and ** indicate P < 0.05 and P < 0.10, respectively.CC BY-NC · PubMed Central
Figure 6. Hepatocyte (PXB) transplantation with L-ECM gel and collagen gel (control) in a drug-induced liver fibrosis rat model. (A) Photographs of the transplantation. The white arrow indicates the peeled-off surface. (B) H&E and azan staining of the resected specimen. L-ECM gel was observed on the liver surface. Red blood cells (yellow arrows) and nuclei cell were observed in the L-ECM gel. Scale bar, 50 μm. (C) Human albumin production in the rat blood samples (n = 3). There was no significant difference between the L-ECM and collagen gels. (D) Gene expression analysis by PCR. ALB was significantly higher in L-ECM gel than in the collagen gel (P < 0.05). Expression of other genes, including CYP3A4, EPCAM, KRT7, ABCB2, LKB1, CLDN1, CLDN2, CCN1, and CCN2 was similar in the two hydrogels. (E) Immunostaining of engrafted hepatocytes (CK8/18, human albumin-positive). The hepatic function marker, CYP3A4, and the tight junction marker ZO-1 were expressed in hepatocytes. Scale bar, 50 μm. (F) The rate of claudin-1 positive area per same square measurement was significantly higher in the L-ECM gel than in the collagen gel (P = 0.024). (G) Pecam1 expression analysis of hepatocytes encapsulated in the L-ECM and collagen gels. A significant difference was observed between the two hydrogels. (H) Angiogenesis in the hydrogel. The rate of CD-31 positive area per graft area was significantly higher in the L-ECM gel than that in the collagen gel (P = 0.014). A vascular structure was observed in the L-ECM gel. Scale bar, 50 μm. * and ** indicate P < 0.05 and P < 0.10, respectively.
Figure 6. Hepatocyte (PXB) transplantation with L-ECM gel and collagen gel (control) in a drug-induced liver fibrosis rat model. (A) Photographs of the transplantation. The white arrow indicates the peeled-off surface. (B) H&E and azan staining of the resected specimen. L-ECM gel was observed on the liver surface. Red blood cells (yellow arrows) and nuclei cell were observed in the L-ECM gel. Scale bar, 50 μm. (C) Human albumin production in the rat blood samples (n = 3). There was no significant difference between the L-ECM and collagen gels. (D) Gene expression analysis by PCR. ALB was significantly higher in L-ECM gel than in the collagen gel (P < 0.05). Expression of other genes, including CYP3A4, EPCAM, KRT7, ABCB2, LKB1, CLDN1, CLDN2, CCN1, and CCN2 was similar in the two hydrogels. (E) Immunostaining of engrafted hepatocytes (CK8/18, human albumin-positive). The hepatic function marker, CYP3A4, and the tight junction marker ZO-1 were expressed in hepatocytes. Scale bar, 50 μm. (F) The rate of claudin-1 positive area per same square measurement was significantly higher in the L-ECM gel than in the collagen gel (P = 0.024). (G) Pecam1 expression analysis of hepatocytes encapsulated in the L-ECM and collagen gels. A significant difference was observed between the two hydrogels. (H) Angiogenesis in the hydrogel. The rate of CD-31 positive area per graft area was significantly higher in the L-ECM gel than that in the collagen gel (P = 0.014). A vascular structure was observed in the L-ECM gel. Scale bar, 50 μm. * and ** indicate P < 0.05 and P < 0.10, respectively.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 63 references

Cited by

See all 11

Metadata

Authors
Udagawa, D., Nagata, S., Yagi, H., Nishi, K., Morisaku, T., Adachi, S., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., Abe, Y., Kitago, M., & Kitagawa, Y.
Affiliations
  • Keio University (JP)
  • National Cancer Center Research Institute (JP)
Corresponding author
Yagi, Hiroshi
Venue
Cell Transplantation
Published
2024-05-21
Volume
33
Pages
9636897241253700-9636897241253700
ISSN
  • 0963-6897 (ISSN-L)
  • 1555-3892
OpenAlex
W4398187981
Cited by
11
References
63
Citations by year
2026: 5 · 2025: 3 · 2024: 3
FWCI
4.63
Type
journal article
Language
en
Open access
Licence
Locations
  • Cell Transplantation (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Japan Agency for Medical Research and Development (22bm1004003h0003)
  • Grant-in-Aid for Challenging Research (22K18395)
  • JSPS KAKENHI Grant-in-Aid for Scientific Researc (23K11833)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
hepatocyte transplantation, extracellular matrix gel, liver fibrosis, orthotopic transplantation, cell engraftment, cell-cell interactions, angiogenesis, albumin synthesis, thioacetamide-induced liver fibrosis, collagen gel, cell aggregates
MeSH terms
Angiogenesis, Animals, Cell Communication, Cells, Cultured, Extracellular Matrix, Humans, Liver, Liver Cirrhosis, Male, Rats, Sprague-Dawley, Neovascularization, Physiologic, Hydrogels, Hepatocytes, Tissue Engineering, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Novel Approach to Orthotopic Hepatocyte Transplantation Engineered With Liver Hydrogel for Fibrotic Livers, Enhancing Cell–Cell Interaction and Angiogenesis. https://app.cochat.ai/papers/10.1177/09636897241253700
The paper
Udagawa, D., Nagata, S., Yagi, H., Nishi, K., Morisaku, T., Adachi, S., Nakano, Y., Tanaka, M., Hori, S., Hasegawa, Y., Abe, Y., Kitago, M., & Kitagawa, Y. (2024). A Novel Approach to Orthotopic Hepatocyte Transplantation Engineered With Liver Hydrogel for Fibrotic Livers, Enhancing Cell–Cell Interaction and Angiogenesis. Cell Transplantation. https://doi.org/10.1177/09636897241253700

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.